In addition, CD19 was revealed to participate in the regulation of constitutive activation of NFκB pathway in chronic lymphocytic leukemia as a role of hematopoietic cell lineage marker.36 The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.